Merck and Co Inc

0.38 (0.34%)


Draw Mode:

Volume 3,149
Bid Price
Ask Price
News (3)
Day High


52 Week Range


Day Low
Share Name Share Symbol Market Stock Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.38 0.34% 113.49 07:21:03
Open Price Low Price High Price Close Price Previous Close
Trades Shares Traded Average Volume 52 Week Range
98 3,149 - 83.05 - 119.65
Last Trade Type Quantity Price Currency
07:23:32 10 US$ 113.37 USD

Merck and Co Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 3.35B 29.52M 2.53B US$ 14.49B US$ 28.97M 1.11 0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- US$ - 2.60% 06/14/23 -74.46k -

more financials information »

Merck News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No MRK Message Board. Create One! See More Posts on MRK Message Board See More Message Board Posts

Historical MRK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week110.04114.48108.47110.948,142,0763.453.14%
1 Month117.82118.625108.47113.486,624,126-4.33-3.68%
3 Months106.14119.65102.44111.377,175,2597.356.92%
6 Months110.36119.6596.36109.978,030,1763.132.84%
1 Year90.17119.6583.05100.558,726,38423.3225.86%
3 Years81.17119.6570.8985.2110,499,90632.3239.82%
5 Years61.51119.6559.8082.4110,399,77351.9884.51%

Merck Description

Pandion Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address the unmet needs of patients suffering from autoimmune diseases. The firm has combined a network-based conceptualization of the immune system in advanced protein engineering to develop TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design and discovery platform. Its pipeline products are PT101, for the treatment of patients with moderate-to-severe ulcerative colitis and the treatment of patients with systemic lupus erythematosus; PT627; PT001; and others.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |

V: D: 20230606 12:41:56